BSE filing, NSE: TATAELXSI. Summary written from the filing by ALFA Finder's alert engine.
Tata Elxsi Ltd: key numbers
- Share price
- ₹3,755.00
- Market cap
- ₹23,396 Cr
- Revenue (annual)
- ₹3,757 Cr
- Net profit (annual)
- ₹628.4 Cr
- P/E (TTM)
- 34.9×Sector 23.0×
- Promoter holding
- 43.89%-0.01% QoQ
- FII holding
- 8.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tata Elxsi Ltd
All →Tata Elxsi Other Announcement
Tata Elxsi Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Tata Elxsi Earnings Call Transcript: Key Takeaways
Tata Elxsi reported steady constant currency revenue growth and margin expansion despite wage hikes.
Tata Elxsi Management Change
Tata Elxsi Limited has appointed Deloitte Haskins & Sells Chartered Accountants LLP as the new statutory auditor for a 60-month term effective from April 1, 2027.
Tata Elxsi Employee Stock Options
Tata Elxsi Limited allotted 686 equity shares to employees upon the exercise of performance stock options. This allotment increases the company's paid-up equity share capital.
Tata Elxsi Investor Presentation: Key Takeaways
Tata Elxsi reported Q2 FY27 revenue of Rs. 1,055.7 Cr, up 3.4% QoQ. Strategy focuses on broad-based growth across Transportation, Media, and Healthcare using GenAI.
Tata Elxsi Results Update
Tata Elxsi reported Q2 FY27 operating revenue of ₹1,055.7 Crore, reflecting a 3.4% QoQ growth. EBITDA for the quarter stood at ₹231.4 Crore.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.